One Health Group Plc (OHGR) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of One Health Group Plc stock £2.62, price £3.05, that is 14.1% below the price, quality 57 out of 100. Rating: overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
20‑month range £1.66 – £3.10 · fair‑value band £1.57 – £4.22 · the £3.05 price screens above the £2.62 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Follow One Health Group in your weekly email
Every Wednesday you see whether One Health Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
One Health Group Plc provides diagnosis and treatment for orthopedics, spine, general surgery, and gynecology patients.
Show moreShow less
It provides treatments for back & spine, elbow, foot & ankle, gynaecology, hernias, hips, knees, lower GI / colorectal, shoulder, upper GI / biliary, urology, and wrist and hand, as well as surgeries, medical, and medico-legal services.
The company was incorporated in 2001 and is based in Sheffield, United Kingdom.
Stock analysis
One Health Group Plc (OHGR) currently trades at £3.05, while our model-based Fair Value estimate is £2.62, 14% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of £3.35 per share, and 7 of the 25 models we run sit above the £3.05 price.
Bear case: the Asset-Based group reads lowest at £0.5900, and 18 of the 25 models stay below the price. Data coverage for this calculation is medium.
Scenario range: £1.57 (bear) to £4.22 (bull), the price of £3.05 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
One Health Group Plc reported revenue of £31.6M in FY2026 versus £20.5M in FY2023, a compound +15.5%/yr. Reported net income was £2.1M in FY2026, compounding +225.9%/yr from FY2023. FY2023 was a trough year, so the rate overstates the trend.
Key figures
Market cap £41.3M Micro · P/E ratio 20.3 · P/S ratio 1.34 · EPS (TTM) £0.1500 · Net margin 6.6% · Return on assets (EBIT) 7.7% (4-year average) · Free cash flow £102K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 2% below its 52-week high and 45% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −14%, OHGR screens richer than that median.
Fair Value models
Bear£1.57Fair Value £2.62Bull£4.22
Price £3.05 · Downside -14.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 7 months old). Earnings retained since then (£0.0916 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+11.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.5%
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
1.1% (2023) → 7.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+79.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.9%
Yearly sales growth analysts expect, extended to five years.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +75.1% a year for the price and +2.5% for the forecasts.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside−14.1% · Below median
Profitability
Return on assets9.7% · Top 25%
Net margin (12 months)6.6% · Above median
Operating margin (12 months)0.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)0.0% · Bottom 25%
Dividend yield (12 months)0.0% · Bottom 25%
Balance sheet
Debt / equity0.08× · Below median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "One Health Group Plc Fair Value". https://www.fairvalue-calculator.com/stock/OHGR
Frequently asked questions
Is One Health Group Plc (OHGR) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of £2.62 versus a price of £3.05, about 14% lower (overvalued).
What is the fair value of OHGR?
Our model-based fair value for One Health Group Plc is £2.62 (as of Nov 9, 2026), built from audited fundamentals. The current price: £3.05.
What is the quality score of OHGR?
One Health Group Plc has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for One Health Group Plc (OHGR)?
Our model-based price target is the fair value of £2.62 (as of Nov 9, 2026) from 25 valuation models. Cautious scenario £1.57, optimistic scenario £4.22. It is a calculation from audited fundamentals, not an analyst target.
What is the One Health Group Plc stock forecast for 2026?
Our models put fair value at £2.62, about 14% lower versus a price of £3.05 (overvalued). Cautious scenario £1.57, optimistic scenario £4.22. The calculation is refreshed regularly with new filings.
What growth is priced into One Health Group Plc (OHGR)?
For today's price to be fair in a discounted-cash-flow model, One Health Group Plc would have to grow free cash flow by +79.1 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 3 years revenue grew +15.5 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of OHGR use?
Our models discount One Health Group Plc at 13.3 %: a base by market capitalisation (micro), country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For One Health Group Plc that is +79.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has One Health Group Plc (OHGR) delivered so far?
Over the past 3 years revenue at One Health Group Plc grew +15.5 % a year. The price currently implies free-cash-flow growth of +79.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of One Health Group Plc (OHGR) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into One Health Group Plc (+79.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of One Health Group Plc (OHGR)?
The free-cash-flow yield on the price is 0.25 %: that much free cash flow One Health Group Plc produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of One Health Group Plc (OHGR)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For One Health Group Plc it is £2.62 per share (as of Nov 9, 2026), against a price of £3.05. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is One Health Group Plc stock overvalued or undervalued in 2026?
As of Nov 9, 2026, OHGR trades above its calculated fair value: price £3.05, fair value £2.62, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OHGR?
No. The price is what the market pays today (£3.05); the fair value is what the company's own numbers justify (£2.62). For One Health Group Plc the two are £0.4300 per share apart. That gap is exactly why we show both numbers side by side.
How much is One Health Group Plc worth?
The market values One Health Group Plc at about £41.3M (market capitalisation, as of Nov 9, 2026). Per share that is £3.05; our models calculate a fair value of £2.62 per share.
What do the bullish and bearish scenarios say about OHGR?
Our models span a range for One Health Group Plc: cautious scenario £1.57, base £2.62, optimistic £4.22 per share (as of Nov 9, 2026, price £3.05). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of OHGR?
One Health Group Plc trades at a price-to-earnings ratio of 20.3 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £2.62 is built from several models across several years. Other multiples: P/B 4.3, EV/EBITDA 15.3.
How solid is the balance sheet of One Health Group Plc (OHGR)?
Balance-sheet figures for One Health Group Plc (as of Nov 9, 2026): debt of 0.08 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is OHGR from its 52-week high?
One Health Group Plc trades at £3.05, about 2% below its 52-week high of £3.10 and 45% above the low of £2.11 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of £2.62 is for.
Which stocks are comparable to One Health Group Plc?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is One Health Group Plc stock attractive at the current price?
The data as of Nov 9, 2026: price £3.05, calculated fair value £2.62 (−14%), Quality Score 57/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OHGR calculated?
We run One Health Group Plc through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of £2.62 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. One Health Group Plc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of One Health Group Plc (OHGR)?
The closing price on Nov 6, 2026 was £3.05. Our model-based fair value is £2.62, about 14% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with One Health Group Plc right now?
The model range is unusually wide (£1.57 to £4.22). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of One Health Group Plc
How large is the market capitalisation of One Health Group Plc (OHGR)?
The market capitalisation of One Health Group Plc is £41.3M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of One Health Group Plc (OHGR)?
The price-to-sales ratio of One Health Group Plc is 1.34 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of One Health Group Plc (OHGR)?
Earnings per share at One Health Group Plc are £0.1500 (price ÷ EPS = P/E 20.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of One Health Group Plc (OHGR)?
The net margin of One Health Group Plc is 6.6% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of One Health Group Plc (OHGR)?
On an EBIT basis the return on assets of One Health Group Plc is 7.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
Free · no account needed
Watch One Health Group Plc in the live analysis
One click puts One Health Group Plc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 9, 2026